Fluorescein

Fluorescein

SCHEMBL1973302

O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21.[Cu]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 8/20 0.97
MAPT P10636 4/20 0.97
MEN1 O00255 4/20 0.97
KMT2A Q03164 4/20 0.97
TDP1 Q9NUW8 3/20 0.97
HTT P42858 2/20 0.97
HPGD P15428 2/20 0.97
RECQL P46063 2/20 0.97
BLM P54132 2/20 0.97
PRMT1 Q99873 2/20 0.97
ACE2 Q9BYF1 2/20 0.97
CYP2C19 P33261 1/20 0.97
SMAD3 P84022 1/20 0.97
LMNA P02545 3/20 0.68
GPR55 Q9Y2T6 2/20 0.68
ALOX12 P18054 2/20 0.68
POLB P06746 1/20 0.68
NPSR1 Q6W5P4 1/20 0.68
ALDH1A1 P00352 3/20 0.61
USP2 O75604 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluorescein SCHEMBL29388667 0.98 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL30272223 0.98 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL3645090 0.98 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL16533 0.98 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL29371199 0.98 FTO (1.00) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL538249 0.97 FTO (0.97) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL21410711 0.97 FTO (0.97) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL3293893 0.97 FTO (0.97) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL20503455 0.97 FTO (0.97) FTOMAPTMEN1KMT2ATDP1
Fluorescein SCHEMBL21194999 0.97 FTO (0.97) FTOMAPTMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170122954-A1 PROFILING REACTIVE OXYGEN, NITROGEN AND HALOGEN SPECIES ENZO LIFE SCIENCES, INC., C/O ENZO BIOCHEM, INC. (US) 2017-05-04 US claimed
US-20150192564-A1 PROFILING REACTIVE OXYGEN, NITROGEN AND HALOGEN SPECIES ENZO LIFE SCIENCES, INC., C/O ENZO BIOCHEM, INC. (US) 2015-07-09 US claimed
EP-2335052-A1 PROFILING REACTIVE OXYGEN, NITROGEN AND HALOGEN SPECIES Enzo Life Sciences, Inc. (US) 2011-06-22 EP claimed
WO-2010036922-A1 PROFILING REACTIVE OXYGEN, NITROGEN AND HALOGEN SPECIES ENZO LIFE SCIENCES, INC. (US) 2010-04-01 WO claimed
US-20100081159-A1 Profiling reactive oxygen, nitrogen and halogen species ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. 2010-04-01 US claimed
US-20170122954-A1 PROFILING REACTIVE OXYGEN, NITROGEN AND HALOGEN SPECIES ENZO LIFE SCIENCES, INC., C/O ENZO BIOCHEM, INC. (US) 2017-05-04 US disclosed
US-9463437-B2 Methods for scavenging nitric oxide using cerium oxide nanoparticles UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2016-10-11 US disclosed
US-20150192564-A1 PROFILING REACTIVE OXYGEN, NITROGEN AND HALOGEN SPECIES ENZO LIFE SCIENCES, INC., C/O ENZO BIOCHEM, INC. (US) 2015-07-09 US disclosed
US-20140227368-A1 METHODS FOR SCAVENGING NITRIC OXIDE USING CERIUM OXIDE NANOPARTICLES UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION INC. (US) 2014-08-14 US disclosed
US-20140179014-A1 FLUORESCENT NITRIC OXIDE PROBES AND ASSOCIATED METHODS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2014-06-26 US disclosed
US-8637323-B2 Fluorescent nitric oxide probes and associated methods BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-01-28 US disclosed
US-20130302903-A1 FLUORESCENT NITRIC OXIDE PROBES AND ASSOCIATED METHODS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-11-14 US disclosed
EP-2561338-A1 FLUORESCENT NITRIC OXIDE PROBES AND ASSOCIATED METHODS Board Of Regents, The University Of Texas System (US) 2013-02-27 EP disclosed
WO-2011133366-A1 FLUORESCENT NITRIC OXIDE PROBES AND ASSOCIATED METHODS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2011-10-27 WO disclosed
EP-2335052-A1 PROFILING REACTIVE OXYGEN, NITROGEN AND HALOGEN SPECIES Enzo Life Sciences, Inc. (US) 2011-06-22 EP disclosed
WO-2010036922-A1 PROFILING REACTIVE OXYGEN, NITROGEN AND HALOGEN SPECIES ENZO LIFE SCIENCES, INC. (US) 2010-04-01 WO disclosed
US-20100081159-A1 Profiling reactive oxygen, nitrogen and halogen species ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. 2010-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130302903-A1 FLUORESCENT NITRIC OXIDE PROBES AND ASSOCIATED METHODS NOS2, NOS3, NOS1 FTO 1169/4885MAPT 4397/4885MEN1 3433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.